Single-cell sequencing analysis reveals cetuximab resistance mechanism and salvage strategy in colorectal cancer
Clin Transl Med
.
2025 Jan;15(1):e70151.
doi: 10.1002/ctm2.70151.
Authors
Shiyun Chen
1
2
,
Zhaoli Tan
1
,
Xiaojie Wu
2
,
Yanli Lin
2
,
Xiang Li
2
,
Yumeng Cui
2
,
Weiling Man
2
,
Fang Pang
1
2
,
Yanghua Li
2
,
Faliang Shi
2
,
Lu Han
1
,
Miaomiao Gou
1
,
Li Zhou
3
,
Zhikuan Wang
1
,
Youliang Wang
2
,
Guanghai Dai
1
Affiliations
1
Department of Oncology, the Fifth Medical Center, Chinese PLA General Hospital, Beijing, China.
2
Laboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China.
3
Department of Sequencing Analysis, Beijing Easyresearch Technology Limited Company, Beijing, China.
PMID:
39739554
PMCID:
PMC11686085
DOI:
10.1002/ctm2.70151
No abstract available
Grants and funding
2019YFA0903800/National Key Research and Development Program of China
2022YFC3600100/National Key Research and Development Program of China
82002474/National Natural Science Foundation of China
82272643/National Natural Science Foundation of China
7222176/Natural Science Foundation of Beijing Municipal